These pathophysiological changes in diabetes, taken together with our tissue-level findings, motivate testing whether gastric ghrelin metrics serve as biomarkers of diabetic gastric involvement and whether targeted modulation of the gastric ghrelin pathway improves gastrointestinal function. Here, GHRL is linked to diabetes mellitus.